FDA's approval earlier this year of Medtronic's Micra pacemaker is just the beginning, says Paul Iaizzo, PhD, professor of surgery, integrative biology and physiology at the University of Minnesota. (See Iaizzo discuss structural heart innovation at MD&M Minneapolis, September 21-22 in Minneapolis.)
"I think the leadless pacemaker technology will be huge globally," Iaizzo says. "There are not enough trained cardiac electrophysiologists worldwide to put in systems with leads.The leadless could open up this, where interventionalists and radiologists could put them in. The Medtronic Micra was FDA approved several months ago. Now to come dual chamber and biV systems."
[Image courtesy of Medtronic]